Don’t miss this engaging article that explores the current and emerging treatment landscape in immune thrombocytopenic purpura (ITP). New therapeutic approaches to ITP are urgently needed to address unmet clinical needs.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.